Codexis (CDXS) Other Non Operating Income (2015 - 2026)
Codexis (CDXS) posted quarterly Other Non Operating Income of -$1.3 million for Q1 2026, down 36.94% year-over-year from -$2.0 million in Q1 2025, and up 19.17% quarter-over-quarter from -$1.6 million in Q4 2025.
Codexis (CDXS) Other Non Operating Income (2015 - 2026) Analysis & Trends
Codexis' Other Non Operating Income history runs 12 years deep, the most recent figure standing at -$1.3 million for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 36.94% year-over-year to -$1.3 million; the TTM figure through Mar 2026 stood at -$5.2 million (up 52.3% YoY), while the FY2025 annual figure was -$4.8 million, up 53.69% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$1.3 million, up from -$1.6 million in the prior quarter.
- The five-year high for Other Non Operating Income was $216000.0 in Q3 2022, with the low at -$8.3 million in Q4 2023.
- The 5-year median for Other Non Operating Income is -$984000.0 (2025), against an average of -$1.7 million.
- The sharpest annual moves came in 2022 and 2023: Other Non Operating Income jumped 96.59% in 2022, then sank 31992.31% in 2023.
- Codexis' Other Non Operating Income stood at -$26000.0 in 2022, then tumbled by 31992.31% to -$8.3 million in 2023, then soared by 52.4% to -$4.0 million in 2024, then soared by 59.82% to -$1.6 million in 2025, then rose by 19.17% to -$1.3 million in 2026.
- Business Quant data shows CDXS's Other Non Operating Income at -$1.3 million in Q1 2026, -$1.6 million in Q4 2025, and -$1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.30 Mn |
| Mar 31, 2026 | -1.29 Mn |
| Dec 31, 2025 | -1.60 Mn |
| Sep 30, 2025 | -1.29 Mn |
| Jun 30, 2025 | -984,000.00 |
| Mar 31, 2025 | -942,000.00 |
| Dec 31, 2024 | -3.97 Mn |
| Sep 30, 2024 | -4.92 Mn |
| Jun 30, 2024 | -985,000.00 |
| Mar 31, 2024 | -516,000.00 |
| Dec 31, 2023 | -8.34 Mn |
| Sep 30, 2023 | -3.90 Mn |
| Jun 30, 2023 | -9,000.00 |
| Mar 31, 2023 | -25,000.00 |
| Dec 31, 2022 | -26,000.00 |
| Sep 30, 2022 | 216,000.00 |
| Jun 30, 2022 | -63,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Dec 31, 2021 | 228,000.00 |
| Sep 30, 2021 | 983,000.00 |